From new kid on the block to leading journal: a review and reflection on the first 20 years of the European Journal of Cardiovascular Nursing.

European Journal Cardiovascular Nursing Allied health Cardiovascular care Cardiovascular nursing Review

Journal

European journal of cardiovascular nursing
ISSN: 1873-1953
Titre abrégé: Eur J Cardiovasc Nurs
Pays: England
ID NLM: 101128793

Informations de publication

Date de publication:
11 01 2022
Historique:
received: 21 10 2021
revised: 18 11 2021
accepted: 18 11 2021
pubmed: 4 1 2022
medline: 1 4 2022
entrez: 3 1 2022
Statut: ppublish

Résumé

This year marks the 20th birthday of the European Journal of Cardiovascular Nursing (EJCN). The official journal of the Association of Cardiovascular Nursing and Allied Professionals, is now recognized as one of the leading nursing and allied professional journals. This article reflects on the developments and impact of the journal over its 20-year lifespan. We present a descriptive account of the journal from inception (2002) until present day (2021), using data provided by the EJCN editorial office and extracted from published and available information. In the last 20 years, the EJCN has published 20 volumes, 106 issues, and 1320 papers from 79 countries. The volume and quality of papers has been consistently increasing, culminating in a 2020 impact factor of 3.908, the highest in its history, ranking second for nursing science. Papers are predominantly patient focused with a range of research methods that cover an extensive range of cardiovascular conditions. Authors who contributed to the first issue continued their contribution; 293 articles in total. The EJCN has evolved into a leading journal of cardiovascular care. As the journal enters its next era, with a new Editor-in-Chief, it is appropriate to have reflected on the phenomenal contribution of the outgoing Editor-in-Chief, and the editorial team, over the last 20 years.

Sections du résumé

BACKGROUND
This year marks the 20th birthday of the European Journal of Cardiovascular Nursing (EJCN). The official journal of the Association of Cardiovascular Nursing and Allied Professionals, is now recognized as one of the leading nursing and allied professional journals.
AIMS
This article reflects on the developments and impact of the journal over its 20-year lifespan.
METHODS AND RESULTS
We present a descriptive account of the journal from inception (2002) until present day (2021), using data provided by the EJCN editorial office and extracted from published and available information. In the last 20 years, the EJCN has published 20 volumes, 106 issues, and 1320 papers from 79 countries. The volume and quality of papers has been consistently increasing, culminating in a 2020 impact factor of 3.908, the highest in its history, ranking second for nursing science. Papers are predominantly patient focused with a range of research methods that cover an extensive range of cardiovascular conditions. Authors who contributed to the first issue continued their contribution; 293 articles in total.
CONCLUSION
The EJCN has evolved into a leading journal of cardiovascular care. As the journal enters its next era, with a new Editor-in-Chief, it is appropriate to have reflected on the phenomenal contribution of the outgoing Editor-in-Chief, and the editorial team, over the last 20 years.

Identifiants

pubmed: 34977936
pii: 6491868
doi: 10.1093/eurjcn/zvab121
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

4-8

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2022. For permissions, please email: journals.permissions@oup.com.

Auteurs

Suzanne Fredericks (S)

ACNAP Science Committee member and Daphne Cockwell School of Nursing, Ryerson University, 288 Church Street; Toronto, ONT; M5B 1Z5, Canada.

Liesbet Van Bulck (L)

ACNAP Young Community National Ambassador and KU Leuven Department of Public Health and Primary Care, KU Leuven - University of Leuven, Leuven, Belgium.
Research Foundation Flanders (FWO), Brussels, Belgium.

Chantal Ski (C)

ACNAP Science Committee member, Integrated Care Academy, University of Suffolk, Ipswich IP4 1QJ, UK.

Anne Kathrine Skibelund (AK)

ACNAP Science Committee member and ESC Patient Forum representative.

Julie Sanders (J)

ACNAP Science Committee Chair and St Bartholomew's Hospital, Barts Health NHS Trust. London EC1A 7BE, UK.
Clinical Professor Cardiovascular Nursing William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH